First Lead-212 (Pb-212) in human images - quite remarkable that Alpha emission can be imaged with this quality. @DrDavePattison@AdvanCell_Iso#PSMA
https://t.co/avzqArzEQI
Targeted alpha therapy with ²¹²Pb-DOTAMTATE in #NETcancer patients has shown great potential, exceeding the standard-of-care treatments currently available; Phase II study coming soon! https://t.co/GjxcH7yjcA @delpassand#Theranostics = #PrecisionOncology
CMS has officially retired national noncoverage language from the books for PET imaging using radiopharmaceuticals for nononcologic indications. #NucMed#radiology https://t.co/6TBbwfMprA
#ASCO21@ASCO Plenary #LBA4 : VISION trial just presented 👏👏177Lu-PSMA-617 is new SOC in “PSMA positive” mCRPC #prostatecancer with prior novel AR inhibitors + taxanes👉Reduces risk of progression by 60% & of death by 38% @Morr316 @oncoalert@PCF_Science@urotoday
Ulaner et al. prospectively detected HER2-positive metastases in women with HER2-negative primary breast cancer using 89-Zr pertuzumab. https://t.co/7Y9Ijnf05e @sloan_kettering #MolecularImaging
The novel radiopharmaceutical 18F-PSMA-1007 is effective and readily available for detecting malignant prostate cancer lesions, according to research published in The Journal of Nuclear Medicine. #ProstateCancer#PrecisionMedicine#NuclearMedicine#JNM https://t.co/YgLh3xdB8p
RADIOLOGY New: Validation of CO-RADS for classifying #COVID19 19 on chest CT; 8 observers, validation with RT-PCR results. https://t.co/bQHCggHRwX #CTRad#radiology@radiology_rsna
As we all do our best to avoid the spread of COVID-19, we would like to respond to concerns regarding ventilation/perfusion (V/Q) lung scans and the risk inherent in the V/Q scan for spread of COVID-19 to patients and staff alike. https://t.co/suhciUGBLM
We are getting some interesting results using ultra-short time-frames for PET imaging - we are starting to be able to directly capture cardiac motion and blood flow. Check out this video:
https://t.co/T0ns836ZyM
Initial results from a first-in-human study show that PET imaging with PD-L1 antibodies outperforms immunohistochemistry- or RNA-sequencing-based biomarkers for prediction of clinical response to #immunotherapy: https://t.co/53bDxM3edf
Sometimes the cause of #LungCancer can be obvious. FDG #PET -positive lung cancer (arrow) and a pack of cigarettes in the pocket (circle) shown together on the scan. #WorldLungCancerDay#prevention
Blue Earth Diagnostics Announces Addition of Axumin® (Fluciclovine F 18) to NCCN Guidelines® for PET Imaging for Suspected Recurrent Prostate Cancer - #ProstateCancer#precisionmedicine#nuclearmedicine - Digital Journal https://t.co/kSJ1FvXKe6